# Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis Infection

> **NCT02512939** · NA · COMPLETED · sponsor: **University College, London** · enrollment: 675 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **PROCEDURE:** blood test, not yet marketed, no trade name

## Key facts

- **NCT ID:** NCT02512939
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-11-30
- **Final completion:** 2016-11-30
- **Target enrollment:** 675 (ACTUAL)
- **Last updated:** 2023-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02512939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02512939, "Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis Infection". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT02512939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*